Your browser doesn't support javascript.
Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer.
Di Noia, V; Pimpinelli, F; Renna, D; Maccallini, M T; Gariazzo, L; Riva, F; Sperandio, E; Giannarelli, D; Cognetti, F.
  • Di Noia V; Medical Oncology 1 Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: vincenzopio.dinoia@ifo.it.
  • Pimpinelli F; Microbiology and Virology Unit, Dermatological Clinical Department, IRCCS San Gallicano Dermatological Institute, Rome, Italy.
  • Renna D; Medical Oncology 1 Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Maccallini MT; Microbiology and Virology Unit, Dermatological Clinical Department, IRCCS San Gallicano Dermatological Institute, Rome, Italy.
  • Gariazzo L; Microbiology and Virology Unit, Dermatological Clinical Department, IRCCS San Gallicano Dermatological Institute, Rome, Italy.
  • Riva F; Microbiology and Virology Unit, Dermatological Clinical Department, IRCCS San Gallicano Dermatological Institute, Rome, Italy.
  • Sperandio E; Department of Clinical and Molecular Medicine, Università La Sapienza di Roma, Rome, Italy.
  • Giannarelli D; Department of Clinical and Molecular Medicine, Università La Sapienza di Roma, Rome, Italy.
  • Cognetti F; Medical Oncology 1 Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy; Biostatistic Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Ann Oncol ; 33(5): 563-565, 2022 05.
Article in English | MEDLINE | ID: covidwho-1698146

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2022 Document Type: Article